Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
REVERSAL OF MULTIDRUG-RESISTANCE TO CANCER-CHEMOTHERAPY 2nd national conference on new oncologic agents : Practical applications
LEYLANDJONES, B., Dalton, W., Fisher, G. A., Sikic, B. I.
WILEY-LISS. 1993: 3484–88
Abstract
In the past few years, the role of membrane-bound transport genes in human disease has been increasingly recognized and understood. Of these genes, the p170 membrane glycoprotein may function as an outward transport pump for many cancer chemotherapeutic drugs associated with the multidrug resistance phenotype. This article reviews the different classes of the current major modulators of multidrug resistance.
View details for Web of Science ID A1993ML14300013
View details for PubMedID 8242580